Status:
COMPLETED
Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Santa Clara Valley Health & Hospital System
Conditions:
Insulin Resistance
Eligibility:
FEMALE
18+ years
Brief Summary
We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.
Detailed Description
Patients are recruited for 3 day continuous glucose monitoring (CGM) plus self-blood glucose monitoring followed by routine diabetes screening at 26-28 weeks gestation to determine if maternal blood g...
Eligibility Criteria
Inclusion
- \- Pregnant patients under 28 weeks gestation
Exclusion
- \- Pre-gestational diabetes
Key Trial Info
Start Date :
December 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00186004
Start Date
December 1 2002
End Date
May 1 2008
Last Update
June 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305